CSN Login
Members Online: 4

You are here

Announcements

Have an announcement? Complete and submit an announcement submission request form. Announcements are selected based on relevance and available space. Selection does not imply endorsement by the American Cancer Society.

Monday, November 13, 2017 - 10:41am

Event (e.g.conference, teleconference, fundraiser, etc.)

Monday, November 13, 2017 - 10:45am

CancerCare, in collaboration with the American Cancer Society, offers free workshops on a variety of cancer-related topics. Unless otherwise noted, all workshops take place from 1:30 - 2:30 pm Eastern Time. For details and to register for a workshop, call 800-813-HOPE (4673), or visit the CancerCare website at www.cancercare.org/connect.

 

11/29 – Advances in the Treatment of Triple Negative Breast Cancer, Part I of Living with Negative Breast Cancer

11/30 – Coping with the Stresses of Caregiving When Your Loved One Has Triple Negative Breast Cancer, Part II of Living with Triple Negative Breast Cancer

12/14 – Update on Chronic Lymphocytic Leukemia (CLL)

12/20 – Update on Clinical Trials & Triple Negative Breast Cancer, Part III of Living with Triple Negative Breast Cancer

1/9 – Medical Update on Ovarian Cancer

1/11 – Update on Glioblastoma

1/23 – Update on Lymphoma from the 2017 American Society of Hematology (ASH) Annual Meeting

3/9 – Treatment Update on Renal Cell Cancer

For more information, contact:
Lorena Tan Wang
800-813-HOPE (4673)
connect@cancercare.org
Friday, November 10, 2017 - 3:47pm

Research study, clinical trial, focus group,etc (Requires IRB review and certification. See here for guidelines.)

Friday, November 10, 2017 - 2:15pm

 

Study Enrollment: Find Your PATHS to Sexual Health and Parenthood

 

Sexual health and fertility are common and distressing concerns among cancer patients, survivors and their intimate partners. In recognition of this, the American Cancer Society and Will2Love have partnered on a research study testing an online, personalized self-help program to address these issues.

 To participate you must:

  

  • Have been diagnosed with cancer, or be the intimate partner of someone diagnosed with cancer

  • Be 18 years of age or older

  • Be a resident of the United States

  • Not yet have subscribed to Will2Love’s self-help programs

    How to get started in 4 easy steps:

     

  • The web address below will take you to a page with information about how we protect your privacy. There you can sign up for the Find Your PATHS study.

  • Complete a brief questionnaire about your background, health, and sexuality.

  • Get free access to our self-help program for up to 6 months.

  • Complete a follow-up questionnaire and rate the program at 3 and 6 months.

     

To learn more about the study or to sign up, click the following link: PATHS Study Enrollment.

 

The above research study announcement posted on Cancer Survivors Network is intended to be informational in nature. The American Cancer Society does not warrant or guarantee the accuracy of the information provided and will not oversee or otherwise be involved in the conduct of the actual research study. We recommend that you consult with your health care provider if you have concerns about your health before participating in any research study. Any information you obtain through CSN announcements should not be used as a substitute for consultation with your health care provider.

For more information, contact:
Leslie Schover
713-408-7219
lschover@gmail.com
Sunday, November 5, 2017 - 5:53pm

Research study, clinical trial, focus group,etc (Requires IRB review and certification. See here for guidelines.)

Sunday, November 5, 2017 - 5:15pm

Are you receiving treatment for cancer and are willing to participate in a research study?

The purpose of the study is to gain an in-depth understanding from people with cancer their experiences in how they report symptoms to their health care provider. By better understanding your experiences may lead to improved methods for patients to self-report their symptoms. 

Researcher at Texas Woman's University, Houston campus, is conducting a study about people experiencing symptoms from their cancer treatment and their experiences of reporting their symptoms to their health care professional. Participation involves talking to the researching about their experience of reporting their symptoms to a health care professional.The conversation is face to face and may take up to an hour but typically takes about 20-30 minutes. To be eligible for the study, you must be 18 years or older, have been diagnosed with cancer or blood (Leukemia, Lymphoma,or Myeloma) cancer and currently receiving cancer treatment, and live in the Houston Metropolitan area. For more informaion or you are interested in participating, please email the researcher at scarrasco@twu.edu.

Thank you for your consideration!

 

The above research study announcement posted on Cancer Survivors Network is intended to be informational in nature. The American Cancer Society does not warrant or guarantee the accuracy of the information provided and will not oversee or otherwise be involved in the conduct of the actual research study. We recommend that you consult with your health care provider if you have concerns about your health before participating in any research study. Any information you obtain through CSN announcements should not be used as a substitute for consultation with your health care provider.

For more information, contact:
Sharyn Carrasco
N/A
scarrasco@twu.edu
Wednesday, November 1, 2017 - 4:07pm

Research study, clinical trial, focus group,etc (Requires IRB review and certification. See here for guidelines.)

Wednesday, November 1, 2017 - 4:30am

What was your experience with the financial costs of cancer treatment?

 

By better understanding your experiences we may be able to help others navigate the financial terrain of cancer. Researchers at University of Louisville Kent School of Social Work are conducting a study about the impact of cancer treatment on the financial well-being and quality of life of cancer survivors. Participation involves completing a 20-30 minute web-based questionnaire. To be eligible for the study, you must be 18 years or older, have been diagnosed with breast cancer or blood (Leukemia, Lymphoma, or Myeloma) cancer within the past five years.

 

This study is supported through a Doctoral Training Grant from the American Cancer Society and has been approved through the University of Louisville IRB: 17.0187.

 

We need your help! How did you manage the costs of your cancer treatment?

If interested in participating follow this link to the survey.

https://qmsweb.louisville.edu/blue/a.aspx?l=3325_1_AAAAAAAAaB8

The above research study announcement posted on Cancer Survivors Network is intended to be informational in nature. The American Cancer Society does not warrant or guarantee the accuracy of the information provided and will not oversee or otherwise be involved in the conduct of the actual research study. We recommend that you consult with your health care provider if you have concerns about your health before participating in any research study. Any information you obtain through CSN announcements should not be used as a substitute for consultation with your health care provider.

 

For more information, contact:
Lisa Smith
502-472-0724
Lcsmit11@louisville.edu
Friday, September 29, 2017 - 12:47pm

Opportunity to Get Involved (e.g. advocacy, volunteer)

Friday, September 29, 2017 - 9:30am

My name of MJ DeCoteau and I am the executive director of Rethink Breast Cancer – a Canadian patient group dedicated to building community for young women dealing with breast cancer and providing support and resources to help them live the best quality of life.

 

We are looking for woman with HR-positive, HER2-negative advanced breast cancer and women who have been treated with ribociclib (Kisqali) to talk about their treatment experience.

 

The Canadian government will soon be reviewing the use of ribociclib to treat HR-positive, HER2-negative advanced breast cancer in postmenopausal women and Rethink Breast Cancer will be making a submission to ensure that patient voices are represented and considered during the review process.

 

We would like to speak with women in the United States or other countries about their experience with HR-positive, HER2-negative advanced breast cancer or being treated with ribociclib.

 

If you are interested in talking about your experiences, we would like to ask you to complete this survey: https://www.surveymonkey.com/r/2C5SNVX

 

If you would like to speak with us directly about your cancer or treatment experience, you can contact Shawna Rich-Ginsberg at shawna@rethinkbreastcancer.com.

 

We would also like to invite your family or friends to talk about their experience caring for a patient being treated with ribociclib: https://www.surveymonkey.com/r/2Q7LKFG

 

Please feel free to resend or repost this message as widely as possible.

 

Click here if you would like more information about Rethink Breast Cancer or the pan-Canadian Oncology Drug Review.

 

MJ DeCoteau

Founder + Executive Director

Rethink Breast Cancer

The above research study announcement posted on Cancer Survivors Network is intended to be informational in nature. The American Cancer Society does not warrant or guarantee the accuracy of the information provided and will not oversee or otherwise be involved in the conduct of the actual research study. We recommend that you consult with your health care provider if you have concerns about your health before participating in any research study. Any information you obtain through CSN announcements should not be used as a substitute for consultation with your health care provider.

For more information, contact:
Adam Waiser
613-266-8939
adamwaiser@hotmail.com
Thursday, September 28, 2017 - 1:02pm

Research study, clinical trial, focus group,etc (Requires IRB review and certification. See here for guidelines.)

Thursday, September 28, 2017 - 11:00am

Are you or do you know a female identical twin affected by breast cancer?  If so, an important study funded by the National Institute of Health and conducted by Dr. Thomas Mack at the USC Keck School of Medicine needs participation to help save lives:  https://pressroom.usc.edu/thomas-m-mack/ and http://keck.usc.edu/faculty/thomas-m-mack/.

To learn more and consider participating in this crucial study, please email Dr. Mack’s team at twinsUSC@usc.edu.

 

 

The above research study announcement posted on Cancer Survivors Network is intended to be informational in nature. The American Cancer Society does not warrant or guarantee the accuracy of the information provided and will not oversee or otherwise be involved in the conduct of the actual research study.  We recommend that you consult with your health care provider if you have concerns about your health before participating in any research study.  Any information you obtain through CSN announcements should not be used as a substitute for consultation with your health care provider.

 

For more information, contact:
Thomas Mack
twinsUSC@usc.edu
Friday, September 8, 2017 - 11:24am

Research study, clinical trial, focus group,etc (Requires IRB review and certification. See here for guidelines.)

Friday, September 8, 2017 - 11:15am

Hello,

 

My name is Basem Gayed and I am a third year dental student at the University of Connecticut School of Dental Medicine. I am working on customer discovery efforts related to a proposed new product for mouth ulcers as a result of cancer treatment. This project is being led by Dr. Rajesh Lalla and is part of the Accelerate UConn program which seeks to advance the development of new products.

 

We are interested in collecting information on the possible need for a new medication to reduce pain due to oral mucositis (mouth sores due to cancer treatment). If you had mouth sores due to chemotherapy or radiation therapy, we would greatly appreciate it if you can take an anonymous survey at the link below. Your participation is voluntary. If you choose to participate, please complete the survey. While complete surveys will provide better data, you may skip questions that you do not feel comfortable answering. Your response to these questions should take between 2-5 minutes to complete. Completion of this survey signifies your consent to participate in the study. The information obtained may help in the development of a new treatment option for this problem. Your survey responses will be recorded in a de-identified manner i.e. no one will be able to connect your responses to your identity from the survey database. Therefore, your confidentiality will be protected.

 

Thank you for your time and consideration. If you have any questions, please send me an email at gayed@uchc.edu.

 

Sincerely,

Basem Gayed

 

Link to survey: https://goo.gl/forms/WbFGcU30BKd4gdgj1

 

The above research study announcement posted on Cancer Survivors Network is intended to be informational in nature. The American Cancer Society does not warrant or guarantee the accuracy of the information provided and will not oversee or otherwise be involved in the conduct of the actual research study.  We recommend that you consult with your health care provider if you have concerns about your health before participating in any research study.  Any information you obtain through CSN announcements should not be used as a substitute for consultation with your health care provider.

For more information, contact:
Basem Gayed
gayed@uchc.edu
Tuesday, August 29, 2017 - 12:17pm

Research study, clinical trial, focus group,etc (Requires IRB review and certification. See here for guidelines.)

Tuesday, August 29, 2017 - 12:00pm

Researchers from the University of Illinois at Urbana-Champaign are conducting an online survey on the exercise programming preferences of adult liver cancer survivors. The survey takes around 25-35 minutes. This study will provide us with information that can help us to tailor physical activity and counseling programs to fit the specific needs of patients and survivors of liver cancer, so that we can develop programs that will best support this community.

Participants will have the option of being entered into a lottery to win one of several $50 Amazon gift cards.

 

Please click on the following link to participate: https://illinoislas.qualtrics.com/jfe/form/SV_bO7Y3e3w2CdT3nv

 

For more information contact:

Jaime Wong

E-mail: jwong34@illinois.edu

Phone: (217) 300-3705 

 

 

The above research study announcement posted on Cancer Survivors Network is intended to be informational in nature. The American Cancer Society does not warrant or guarantee the accuracy of the information provided and will not oversee or otherwise be involved in the conduct of the actual research study.  We recommend that you consult with your health care provider if you have concerns about your health before participating in any research study.  Any information you obtain through CSN announcements should not be used as a substitute for consultation with your health care provider.

For more information, contact:
Jaime Wong
(217) 300-3705
jwong34@illinois.edu
Wednesday, August 2, 2017 - 12:23pm

Research study, clinical trial, focus group,etc (Requires IRB review and certification. See here for guidelines.)

Wednesday, August 2, 2017 - 12:15pm

Purpose: The American Cancer Society is testing a modified version of the Cancer Survivors Network (CSN) and is inviting you to try it. This research is being done in collaboration with Carnegie Mellon University and is sponsored by the National Institutes of Health.

 

Procedure: Your participation is voluntary.  If you agree, you will use a modified version of CSN to participate in the community.  You will have access to all CSN content, and any posts or comments you make will be added to the CSN community, just as they are now. What is new is that you will see recommendations for content and other members that might interest you. These recommendations are based on what you have read on CSN. As you read more discussion threads, the recommended content and members will be updated. You will occasionally receive a survey to get your feedback on the new interface. We will also ask about the relevance and value of the recommended content.   These surveys will take less than three minutes to complete, and you will receive them at most once per week. We will also invite a small number of members to give more extensive feedback through a phone interview.

 

To participate in this trial, click this link: Yes, I’ll use the new CSN interface.  You can always opt-out later by clicking ‘the use the traditional CSN design’ button on your CSN user profile.

 

Principal investigators:

Robert Kraut, PhD

Herbert A. Simon Professor of Human-Computer Interaction

Carnegie Mellon University

Pittsburgh PA 15213

412 268-7694

robert.kraut@cmu.edu

 

Tenbroeck Smith

Director of Patient Reported Outcomes Research, Behavioral Research Center

American Cancer Society

Atlanta GA

 

tenbroeck.smith@cancer.org

For more information, contact:
Robert Kraut
(412) 268-7694
robert.kraut@cmu.edu
Friday, July 28, 2017 - 8:27pm

Research study, clinical trial, focus group,etc (Requires IRB review and certification. See here for guidelines.)

Wednesday, June 14, 2017 - 10:30am

The University of South Carolina College of Nursing, in partnership with the American Cancer Society’s Reach to Recovery® Program, is recruiting participants for a research study.

Are you a breast cancer survivor and want to become more physically active? Moving Forward Together 3, a home-based exercise research study, may be for you.

Please see study brochure below.

For questions and/or additional information about the study, call 1-888-829-1916 or email CHAPMAKP@mailbox.sc.edu or visit uof.sc/nursing-movingforward.

Participants do not have to live in South Carolina, but they must live in the Eastern time zone to participate.

 

The above research study announcement posted on Cancer Survivors Network is intended to be informational in nature. The American Cancer Society does not warrant or guarantee the accuracy of the information provided and will not oversee or otherwise be involved in the conduct of the actual research study.  We recommend that you consult with your health care provider if you have concerns about your health before participating in any research study.  Any information you obtain through CSN announcements should not be used as a substitute for consultation with your health care provider.

 

 

For more information, contact:
Kimberly Bowyer
1-888-829-1916
CHAPMAKP@mailbox.sc.edu

Pages